Angewandte
Chemie
[1]a) O. Igoucheva, V. Alexeev, K. Yoon, Curr. Mol. Med. 2004, 4,
445 – 463; b) S. Buchini, C. J. Leumann, Curr. Opin. Chem. Biol.
2003, 7, 717 – 726.
[2]D. Praseuth, A. L. Guieysse, C. Helene, Biochim. Biophys. Acta
1999, 1489, 181 – 206.
[3]A. J. Cheng, J. C. Wang, M. W. Van Dyke, Antisense Nucleic
Acid Drug Dev. 1998, 8, 215 – 225.
[4]a) P. Aich, T. J. Thomas, J. S. Lee, Nucleic Acids Res. 2000, 28,
2307 – 2310; b) S. B. Noonberg, J.-C. Francois, T. Garestier, C.
Helene, Nucleic Acids Res. 1995, 23, 1956 – 1963.
[5]G. E. Plum, D. S. Pilch, S. F. Singleton, K. J. Breslauer, Annu.
Rev. Biophys. Biomol. Struct. 1995, 24, 319 – 350.
[6]a) D. A. Horne, P. B. Dervan, J. Am. Chem. Soc. 1990, 112, 2435 –
2437; b) S. D. Jayasena, B. H. Johnston, Biochemistry 1992, 31,
320 – 327.
[7]a) L. De Napoli, G. Di Fabio, A. Messere, D. Montesarchio, A.
Pepe, G. Piccalli, M. Varra, J. Org. Chem. 1997, 62, 9024 – 9030;
b) L. De Napoli, G. Di Fabio, A. Messere, D. Montesarchio, G.
Piccalli, M. Varra, Eur. J. Org. Chem. 1998, 2119 – 2125.
[8]a) Y. Ueno, A. Ogawa, A. Nakagawa, A. Matsuda, Bioorg. Med.
Chem. Lett. 1996, 6, 2817 – 2822; b) C. H. Jessen, E. B. Pedersen,
Helv. Chim. Acta 2004, 87, 2465 – 2471; c) U. Asseline, V. Roig,
N. T. Thuong, Tetrahedron Lett. 1998, 39, 8991 – 8994.
[9]A. V. Maksimenko, E. M. Volkov, J. R. Bertrand, H. Porumb, C.
Malvy, Z. A. Shabarova, M. B. Gottikh, Eur. J. Biochem. 2000,
267, 3592 – 3603.
[10]a) L. De Napoli, G. Di Fabio, A. Messere, D. Montesarchio, D.
Musumeci, G. Piccalli, Nucleosides Nucleotides 1999, 18, 1639 –
1640; b) S. Hoshika, Y. Ueno, H. Kamiya, A. Matsuda, Bioorg.
Med. Chem. Lett. 2004, 14, 3333 – 3336; c) C. Giancola, L.
Petraccone, M. Pieri, L. De Napoli, D. Montesarchio, G. Piccalli,
G. Barone, Int. J. Biol. Macromol. 2001, 28, 387 – 394.
[11]a) J. Amato, A. Galeone, G. Oliviero, L. Mayol, G. Piccialli, M.
Varra, Eur. J. Org. Chem. 2004, 2119 – 2125; b) B. Catalanotti, C.
Fattorusso, L. Mayol, G. Oliviero, G. Piccialli, M. Varra,
Nucleosides Nucleotides Nucleic Acids 2003, 22, 1069 – 1071;
c) T. Miyashita, N. Matsumo, T. Moriguchi, K. Shinozuka,
Tetrahedron Lett. 2003, 44, 7399 – 7402; d) A. T. M. Z. Azam,
M. Hasegawa, T. Moriguchi, K. Shinozuka, Bioorg. Med. Chem.
Lett. 2004, 14, 5747 – 5750; e) Y. Ueno, M. Mikawa, S. Hoshika,
A. Matsuda, Bioconjugate Chem. 2001, 12, 635 – 642.
[12]a) C. Giovannangeli, L. Perrouault, C. Escude, T. Nguyen, C.
Helene, Biochemistry 1996, 35, 10539 – 10548; b) C. Giovan-
nangeli, L. Perrouault, C. Escude, S. Gryaznov, C. Helene, J.
Mol. Biol. 1996, 261, 386 – 398.
[13]L. E. Xodo, G. Manzini, F. Quadrifoglio, G. A. van der Marel,
J. H. Boom, Nucleic Acids Res. 1991, 19, 5625 – 5631.
[14]V. V. Filichev, E. B. Pedersen, J. Am. Chem. Soc. 2005, 127,
14849 – 14858.
[15]a) B. C. Froehler, S. Wadwani, T. J. Terhorst, S. R. Gerrard,
Tetrahedron Lett. 1992, 33, 5307 – 5310; b) J. Sꢀgi, A. Szemzꢁ, K.
ꢂbinger, A. Szabolcs, G. Sꢀgi, E. Ruff, L. ꢃtvꢁs, Tetrahedron
Lett. 1993, 34, 2191 – 2194; c) N. Colocci, P. B. Dervan, J. Am.
Chem. Soc. 1994, 116, 785 – 786.
[16]More detailed information about the molecular modeling
studies and pictures of the alternative positioning of linkers
are given in the Supporting Information.
[17]The synthesis of DMT-protected phosphoramidites of linkers
2
and 3, their incorporations into DNA, MALDI-TOF analysis of
the final TFOs, and details about thermal stability measurements
along with the representative first derivatives of the melting
curves are described in the Supporting Information.
[18]V. V. Demidov, M. D. Frank-Kamenetskii, Trends Biochem. Sci.
2004, 29, 62 – 71.
Angew. Chem. Int. Ed. 2006, 45, 5311 –5315
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
5315